JPRN-UMIN000005911已完成1 期
Phase I study for dose escalation in limited small cell lung cancer - Phase I study for dose escalation in limited small cell lung cancer
Graduate School of Medical Science, Kyoto Prefectural University of Medicine0 个研究点目标入组 30 人开始时间: 2011年7月2日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Uncontrollable DM 2) Collagen disease 3) Concurrent cancer with activity 4) Pregnant 5) Elonging treatment time
研究者
相似试验
已完成
不适用
A Phase 1, Dose Escalation Study to Evaluate the safety tolerability and pharmacokinetics of single oral doses of ELND007 in healthy elderly subjects.dementiaAlzheimerNL-OMON34459Elan Pharma42
进行中（未招募）
1 期
A clinical gene therapy study with hematopoietic stem cells for the treatment of patients suffering from a malignant neoplasm of the central nervous systemGlioblastoma MultiformeEUCTR2018-001404-11-ITGENENTA SCIENCE SR21
已完成
不适用
A phase I, open-label, dose escalation study to investigate the safety, pharmacokinetics, pharmacodynamics and clinical activity of GSK3326595 in subjects with solid tumors and non-Hodgkin*s lymphoma.solid tumors, non-hodgkin's lymphomasolid tumors and non-Hodgkins lymphomaNL-OMON53127GlaxoSmithKline39
进行中（未招募）
1 期
A Clinical Study to investigate the Safety and Tolerability of VAL201 (new trial drug) in Patients with Locally Advanced or Metastatic (cancer cells which spreads from one part of the body to another) Prostate Cancer and Other Advanced Solid Tumours.EUCTR2013-004009-25-GBValiRx plc81
招募中
1 期
Study of PF-07248144 in Advanced or Metastatic Solid Tumorsocally Advanced or Metastatic ER+ HER2- Breast Cancer, CRPC, NSCLCJPRN-jRCT2031200246Kawai Norisuke186